Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
In Vivo. 2012 Sep-Oct;26(5):743-58.

Analysis of minocycline as a countermeasure against acute radiation syndrome.

Author information

  • 1Department of Basic Sciences, Loma Linda University and Medical Center, Loma Linda, CA 92354, USA.

Abstract

BACKGROUND/AIM:

To evaluate the impact of an antibiotic, minocycline, on several immune parameters in response to radiation in a mouse model.

MATERIALS AND METHODS:

C57BL/6 mice were treated with minocycline (i.p.) for 5 days, beginning immediately before radiation with 1-3 Gy (60)Co γ-rays. Spleen and blood were collected on day 4 post-irradiation. Cell populations were determined in the blood and spleen. Splenocytes were activated with anti-CD3 antibody for 48 h and cytokines were quantified.

RESULTS:

Minocycline increased the counts and/or percentages of splenic macrophages, granulocytes, natural killer, T- and CD8(+) T-cells (p<0.05 versus radiation alone). Minocycline significantly increased the expression of interleukin-1α and β, which are radioprotective, as well as the ones of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor, which accelerate neutrophil recovery (p<0.05 versus radiation alone), while suppressing cytokines that could prevent hematopoiesis, e.g. macrophage inflammatory protein-1α, tumor necrosis factor-α and interferon-γ.

CONCLUSION:

These data indicate that minocycline should be further tested for use in restoration of the hematopoietic system after radiation exposure.

PMID:
22949587
[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk